Back
ESC Premium Access

Severe pulmonary hypertension in patients eligible for heart transplantation. Is irreversible pulmonary hypertension still a contraindication?

Session: Poster Session 3 - Chronic heart failure – Treatment
Topic: Heart Transplantation
Speaker: Doctor F. de Frutos Seminario (Barcelona, ES)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Fernando de Frutos Seminario

University Hospital of Bellvitge, Barcelona (Spain)
1 follower

7 more presentations in this session

Vertebral fractures and bone metabolism impairment after heart transplant: results from a prospective cohort study

Speaker: Doctor L. Seguro (Sao Paulo, BR)

Access
Abstract
Slides
Like
Thumbnail

Rejection diagnostics with digital droplet PCR measuring donor-derived cell-free DNA: A retrospective proof-of-concept study in heart-transplanted patients

Speaker: Doctor J. Boehmer (Gothenburg, SE)

Access
Abstract
Slides
Like
Thumbnail

Quality of life in recipients after heart transplantation

Speaker: Doctor M. Simonenko (Saint Petersburg, RU)

Access
Abstract
Slides
Like
Thumbnail

Elevated PCSK9 levels may contribute to dyslipidemia early after cardiac trasplantation

Speaker: Doctor V. Melenovsky (Prague, CZ)

Access
Abstract
Slides
Like
Thumbnail

Effect of left ventricular assist device implantation on complement activation of the cardiac allograft in the early post-heart transplant course

Speaker: Doctor A. Schneider (Copenhagen, DK)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Chronic heart failure – Treatment

Speakers: Doctor F. de Frutos Seminario, Doctor L. Seguro, Doctor J. Boehmer, Doctor M. Simonenko, Doctor V. Melenovsky...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources